Your browser is no longer supported. Please, upgrade your browser.
Settings
ANIK Anika Therapeutics, Inc. daily Stock Chart
ANIK [NASD]
Anika Therapeutics, Inc.
Index- P/E18.49 EPS (ttm)2.06 Insider Own1.30% Shs Outstand14.24M Perf Week3.14%
Market Cap542.40M Forward P/E29.99 EPS next Y1.27 Insider Trans-1.59% Shs Float13.66M Perf Month16.73%
Income29.90M PEG1.85 EPS next Q0.39 Inst Own95.50% Short Float19.23% Perf Quarter14.14%
Sales109.00M P/S4.98 EPS this Y-34.90% Inst Trans4.06% Short Ratio12.79 Perf Half Y12.23%
Book/sh18.97 P/B2.01 EPS next Y1.60% ROA10.70% Target Price40.50 Perf Year-3.57%
Cash/sh11.71 P/C3.25 EPS next 5Y10.00% ROE11.60% 52W Range28.54 - 46.43 Perf YTD13.33%
Dividend- P/FCF17.67 EPS past 5Y-1.70% ROI6.50% 52W High-17.96% Beta1.30
Dividend %- Quick Ratio16.10 Sales past 5Y7.10% Gross Margin71.80% 52W Low33.46% ATR1.51
Employees133 Current Ratio18.10 Sales Q/Q16.00% Oper. Margin32.20% RSI (14)61.59 Volatility3.88% 4.68%
OptionableYes Debt/Eq0.00 EPS Q/Q169.10% Profit Margin27.40% Rel Volume0.73 Prev Close37.28
ShortableYes LT Debt/Eq0.00 EarningsMay 02 AMC Payout0.00% Avg Volume205.41K Price38.09
Recom2.00 SMA202.49% SMA5014.07% SMA2005.01% Volume149,326 Change2.17%
Feb-22-19Downgrade Sidoti Buy → Neutral $56 → $41
Feb-22-19Downgrade First Analysis Sec Outperform → Neutral $41 → $37
Jul-27-18Upgrade Barrington Research Mkt Perform → Outperform $48
Jun-20-18Downgrade First Analysis Sec Overweight → Equal-Weight $45 → $34
Jun-20-18Downgrade Barrington Research Outperform → Mkt Perform
May-04-18Upgrade Barrington Research Mkt Perform → Outperform $39
Feb-23-18Downgrade Barrington Research Outperform → Mkt Perform
Jan-24-18Upgrade First Analysis Sec Equal-Weight → Overweight $45 → $68
Oct-27-17Reiterated Barrington Research Outperform $53 → $57
May-09-16Upgrade Singular Research BUY - Long-Term → Buy $60
Apr-27-16Downgrade Northland Capital Outperform → Market Perform
Feb-26-16Reiterated Barrington Research Outperform $45 → $49
Oct-12-15Initiated Barrington Research Outperform $39
Aug-28-15Initiated First Analysis Sec Equal-Weight
Jul-30-15Reiterated Northland Capital Outperform $56 → $57
May-14-15Initiated Northland Capital Outperform $56
Nov-12-14Reiterated Singular Research BUY - Long-Term $51.50 → $45.50
Aug-19-14Downgrade Singular Research Buy → BUY - Long-Term $54 → $51.50
May-28-14Reiterated Singular Research Buy $43.50 → $54
Apr-08-14Reiterated Singular Research Buy $35 → $43.50
May-24-19 11:43AM  Guardant Health (GH) Looks Good: Stock Adds 6% in Session Zacks
10:53AM  Agenus' (AGEN) Pipeline Progression on Track Amid Competition Zacks
May-23-19 02:25PM  Affimed (AFMD) Earnings and Sales Exceed Estimates in Q1 Zacks
May-22-19 09:44AM  OncoSec Medical (ONCS) Looks Good: Stock Adds 6.6% in Session Zacks
May-20-19 03:06PM  Dr. Reddy's (RDY) Q4 Earnings Up Y/Y, Revenues Top Estimates Zacks
May-16-19 08:42AM  BioMarin (BMRN) in Focus: Stock Moves 7.5% Higher Zacks
May-14-19 09:05AM  Regeneron (REGN) Gets FDA Nod for Eylea Label Expansion Zacks
08:41AM  Twist Bioscience (TWST) Catches Eye: Stock Jumps 8% Zacks
May-13-19 09:13AM  Achillion (ACHN) Reports Wider-Than-Expected Loss in Q1 Zacks
08:30AM  Anika to Showcase Regenerative Medicine and Orthobiologics Portfolio at the 12th Biennial International Society of Arthroscopy, Knee Surgery and Orthopaedic Sports Medicine Congress Business Wire
05:36AM  Will Anika Therapeutics Continue to Surge Higher? Zacks
May-09-19 08:34PM  Heres What Hedge Funds Think About Anika Therapeutics, Inc. (ANIK) Insider Monkey
May-08-19 04:13PM  6 Stocks That Popped Last Week Zacks
May-06-19 08:30AM  Anika to Participate in Two Investor Events in May 2019 Business Wire
07:23AM  What You Must Know About Anika Therapeutics, Inc.'s (NASDAQ:ANIK) Beta Value Simply Wall St.
May-02-19 10:26PM  Anika Therapeutics Inc (ANIK) Q1 2019 Earnings Call Transcript Motley Fool
06:25PM  Anika Therapeutics (ANIK) Q1 Earnings and Revenues Top Estimates Zacks
05:19PM  Anika: 1Q Earnings Snapshot Associated Press
04:05PM  Anika Reports First Quarter 2019 Financial Results Business Wire
04:02PM  Anika Announces $50 Million Share Repurchase Program Business Wire
Apr-30-19 04:05PM  Anika Appoints Stephen Goldy as Vice President of U.S. Sales Business Wire
Apr-25-19 10:34AM  Anika Therapeutics (ANIK) Reports Next Week: Wall Street Expects Earnings Growth Zacks
Apr-18-19 04:05PM  Anika to Issue First-Quarter 2019 Financial Results and Business Highlights on Thursday, May 2 Business Wire
Apr-04-19 03:33PM  Imagine Owning Anika Therapeutics (NASDAQ:ANIK) And Wondering If The 33% Share Price Slide Is Justified Simply Wall St.
Apr-03-19 04:05PM  Anika to Highlight Regenerative Medicine and Orthobiologics Portfolio at 2019 Asia Pacific Orthopaedic Association Sports Meeting Business Wire
Mar-18-19 08:30AM  Anika Appoints Robert Richard, Ph.D. as Vice President of Research and Development Business Wire
Mar-11-19 04:05PM  Anika to Showcase Commercial and Pipeline Portfolio at 2019 AAOS Annual Meeting Business Wire
Mar-06-19 02:20AM  Edited Transcript of ANIK earnings conference call or presentation 27-Feb-04 4:00pm GMT Thomson Reuters StreetEvents
02:18AM  Edited Transcript of ANIK earnings conference call or presentation 17-Mar-10 1:00pm GMT Thomson Reuters StreetEvents
Mar-01-19 06:35AM  Edited Transcript of ANIK earnings conference call or presentation 21-Feb-19 10:00pm GMT Thomson Reuters StreetEvents
Feb-22-19 09:46AM  Anika Therapeutics (ANIK) Q4 2018 Earnings Conference Call Transcript Motley Fool -16.18%
Feb-21-19 06:55PM  Anika Therapeutics (ANIK) Q4 Earnings and Revenues Top Estimates Zacks
06:01PM  Anika: 4Q Earnings Snapshot Associated Press
04:05PM  Anika Reports Fourth Quarter and Full Year 2018 Financial Results Business Wire
Feb-20-19 12:05PM  How Financially Strong Is Anika Therapeutics, Inc. (NASDAQ:ANIK)? Simply Wall St.
Feb-14-19 10:31AM  Analysts Estimate Anika Therapeutics (ANIK) to Report a Decline in Earnings: What to Look Out for Zacks
Feb-07-19 04:05PM  Anika to Issue Fourth-Quarter and Full-Year 2018 Financial Results and Business Highlights on Thursday, February 21 Business Wire
Feb-01-19 07:35AM  New Research: Key Drivers of Growth for Cisco, Landstar System, Central Garden & Pet, Anika Therapeutics, Hibbett Sports, and MoneyGram International Factors of Influence, Major Initiatives and Sustained Production GlobeNewswire
Jan-21-19 11:58AM  When Should You Buy Anika Therapeutics, Inc. (NASDAQ:ANIK)? Simply Wall St.
Jan-16-19 04:05PM  Anika Announces Plans to Showcase HYALOFAST at the International Cartilage Regeneration and Joint Preservation Society (ICRS) Summit in San Diego Business Wire
Jan-14-19 09:30AM  ANIK or TECH: Which Is the Better Value Stock Right Now? Zacks
Dec-27-18 03:13PM  6 Undervalued Stocks With Positive Earnings Growth Estimates GuruFocus.com
Dec-24-18 09:26AM  Alexion's Ultomiris Gets Early FDA Nod for Rare Blood Disorder Zacks
Dec-23-18 12:00PM  Hedge Funds Are Dumping Anika Therapeutics, Inc. (ANIK) Insider Monkey
Dec-21-18 09:19AM  Agenus' Stock Up 23% on Immuno-Oncology Deal With Gilead Zacks
Dec-20-18 12:39PM  Do You Know What Anika Therapeutics, Inc.s (NASDAQ:ANIK) P/E Ratio Means? Simply Wall St.
Dec-17-18 09:30AM  ANIK vs. RGEN: Which Stock Should Value Investors Buy Now? Zacks +5.62%
Dec-14-18 07:59AM  5 Biotech Stocks Set to Bounce Back in '19 After a Rough Ride Zacks
07:57AM  Anika Therapeutics Enters Oversold Territory Zacks
Dec-12-18 08:00AM  Anika to Showcase HYALOFAST at the International Cartilage Regeneration and Joint Preservation Society (ICRS) Focus Meeting in Milan Business Wire
Dec-10-18 08:44AM  Why Abeona Therapeutics (ABEO) Could Be Positioned for a Slump Zacks
Dec-04-18 04:05PM  Anika Resumes Global Distribution of HYALOFAST, HYALOGRAFT-C and HYALOMATRIX Business Wire -6.06%
Nov-13-18 02:43PM  Is Anika Therapeutics Incs (NASDAQ:ANIK) ROE Of 7.5% Concerning? Simply Wall St.
Nov-02-18 08:55AM  New Research: Key Drivers of Growth for Edison International, NuVasive, LogMein, Anika Therapeutics, First Industrial Realty Trust, and ON Semiconductor Factors of Influence, Major Initiatives and Sustained Production GlobeNewswire
Oct-29-18 09:30AM  ANIK vs. RGNX: Which Stock Should Value Investors Buy Now? Zacks
Oct-25-18 10:16AM  Edited Transcript of ANIK earnings conference call or presentation 24-Oct-18 9:00pm GMT Thomson Reuters StreetEvents -8.76%
08:03AM  The Daily Biotech Pulse: AbbVie Takes Full Control Of Cystic Fibrosis Program, Amgen Slashes Cholesterol Drug Price Benzinga
Oct-24-18 08:02PM  Anika Therapeutics Inc (ANIK) Q3 2018 Earnings Conference Call Transcript Motley Fool
05:25PM  Anika Therapeutics (ANIK) Q3 Earnings Beat Estimates Zacks
04:17PM  Anika: 3Q Earnings Snapshot Associated Press
04:05PM  Anika Reports Third Quarter 2018 Financial Results Business Wire
08:30AM  Susan Vogt Appointed to Board of Directors of Anika Therapeutics Business Wire
Oct-22-18 11:22AM  What's in Store for Anika Therapeutics (ANIK) in Q3 Earnings? Zacks
Oct-17-18 10:32AM  Anika Therapeutics (ANIK) Q3 Earnings Preview: What to Look Out For Zacks
Oct-11-18 08:15AM  Market Trends Toward New Normal in Park Hotels & Resorts, Safety Insurance Group, Cincinnati Financial, Anika Therapeutics, CME Group, and Midstates Petroleum Emerging Consolidated Expectations, Analyst Ratings GlobeNewswire
Oct-10-18 04:05PM  Anika to Issue Third-Quarter 2018 Financial Results and Business Highlights on Wednesday, October 24 Business Wire
Sep-28-18 10:58AM  Ultragenyx Reports Top-line Data From Gene Therapy Candidate Zacks
Sep-27-18 08:49AM  AVEO Pharmaceuticals (AVEO) Soars: Stock Adds 6.4% in Session Zacks
Sep-26-18 08:59AM  Novavax (NVAX) Catches Eye: Stock Jumps 7.6% Zacks
Sep-25-18 11:18AM  Arena (ARNA) Posts Favorable Top-Line Data on Pain Candidate Zacks
10:52AM  FDA Lifts Clinical Hold on Epizyme's Lead Candidate's Study Zacks
10:44AM  FDA Lifts Clinical Hold on Sarepta's DMD Gene Therapy Program Zacks
08:50AM  Alexion Pharmaceuticals (ALXN) Surges: Stock Moves 5.3% Higher Zacks
Sep-05-18 04:05PM  Anika to Participate in the 2018 Morgan Stanley Global Healthcare Conference on September 12, 2018 Business Wire
04:05PM  Anika Appoints Dr. Cheryl Blanchard to Its Board of Directors Business Wire
Sep-04-18 09:28AM  How Financially Strong Is Anika Therapeutics Inc (NASDAQ:ANIK)? Simply Wall St.
Aug-07-18 09:30AM  ANIK vs. ALKS: Which Stock Is the Better Value Option? Zacks
07:50AM  Analysis: Positioning to Benefit within Anika Therapeutics, Ameris, Century Communities, Energous, Consolidated Communications, and Globalstar Research Highlights Growth, Revenue, and Consolidated Results GlobeNewswire
Aug-01-18 09:29PM  Edited Transcript of ANIK earnings conference call or presentation 26-Jul-18 1:00pm GMT Thomson Reuters StreetEvents
Jul-31-18 07:15AM  Blog Exposure - CHMP Adopts Positive Opinion for Alnylams Patisiran for HATTR Amyloidosis Treatment ACCESSWIRE
Jul-26-18 05:03AM  Anika: 2Q Earnings Snapshot Associated Press +19.72%
Jul-25-18 04:05PM  Anika Reports Second Quarter 2018 Financial Results Business Wire
09:52AM  Anika Therapeutics Q2 Earnings Outlook Benzinga
Jul-11-18 04:05PM  Anika to Issue Second-Quarter 2018 Financial Results and Business Highlights on Wednesday, July 25 Business Wire
Jun-22-18 01:04PM  2 Biotech Stocks That Tanked This Week: Can They Recover? Motley Fool
Jun-21-18 04:14PM  Anika Reports Top Line Data from CINGAL Study, Shares Slump Zacks
08:39AM  Benzinga's Daily Biotech Pulse: AbbVie Launches New Pediatric Humira, IPO Deluge Hits The Street Benzinga
08:15AM  Today's Research Reports on Stocks to Watch: Anika Therapeutics and Tesaro ACCESSWIRE
Jun-20-18 04:46PM  Why Pivotal Software, Anika Therapeutics, and Oracle Slumped Today Motley Fool -37.62%
11:41AM  Why Anika Therapeutics, Inc. Stock Is Sinking Motley Fool
08:36AM  Benzinga's Daily Biotech Pulse: Sarepta's DMD Gene Therapy, Anika's Flunked Trial, Eidos To Commence Trading Benzinga
08:32AM  Biotech Stock Roundup: SRPT & SLDB Soar on Positive Data, ANIK & ZIOP Crash Zacks
Jun-19-18 04:05PM  Anika Therapeutics Announces Top-Line Results from CINGAL 16-02 Clinical Trial in Knee Osteoarthritis Business Wire
May-23-18 04:05PM  Anika Therapeutics Announces $30 Million Accelerated Share Repurchase Business Wire
May-18-18 08:44AM  Weakness Seen in Anika Therapeutics (ANIK) Estimates: Should You Stay Away? Zacks
May-16-18 03:52PM  Edited Transcript of ANIK earnings conference call or presentation 3-May-18 1:00pm GMT Thomson Reuters StreetEvents
May-08-18 04:05PM  Anika to Showcase Commercial and Pipeline Portfolio at 18th Bi-Annual European Society for Sports Traumatology, Knee Surgery and Arthroscopy Congress Business Wire
May-02-18 06:19PM  Anika: 1Q Earnings Snapshot Associated Press
04:05PM  Anika Reports First Quarter 2018 Financial Results Business Wire
11:46AM  How Did Anika Therapeutics Incs (NASDAQ:ANIK) 12.08% ROE Fare Against The Industry? Simply Wall St.
Anika Therapeutics, Inc., together with its subsidiaries, provides orthopedic medicines for patients with degenerative orthopedic diseases and traumatic conditions in the United States and internationally. The company develops, manufactures, and commercializes therapeutic products based on its proprietary hyaluronic acid (HA) technology. Its orthobiologics products comprise ORTHOVISC, ORTHOVISC mini, MONOVISC, and CINGAL for the treatment of osteoarthritis of the knee; HYALOFAST, a biodegradable support for human bone marrow mesenchymal stem cells used for cartilage regeneration and as an adjunct for microfracture surgery; HYALONECT, a resorbable knitted fabric mesh; HYALOSS MATRIX, HYAFF fibers used to mix blood/bone grafts to form a paste for bone regeneration; and HYALOGLIDE, an ACP gel used in tenolysis treatment. The company's dermal products include wound care products that comprise HYALOMATRIX and HYALOFILL for the treatment of complex wounds, such as burns and ulcers, and for use in connection with the regeneration of skin; and ELEVESS, an aesthetic dermatology product. Its surgical products comprise HYALOBARRIER, a post-operative adhesion barrier for use in the abdomino-pelvic area; MEROGEL, a woven fleece nasal packing; and MEROGEL INJECTABLE, a viscous hydrogel. The company also offers ophthalmic products, including injectable HA products that are used as viscoelastic agents in ophthalmic surgical procedures, such as cataract extraction and intraocular lens implantation; and veterinary products, which include HYVISC, an injectable HA product for the treatment of joint dysfunction in horses. The company was founded in 1983 and is headquartered in Bedford, Massachusetts.
Insider Trading Relationship Date Transaction Cost #Shares Value ($) #Shares Total SEC Form 4
Darling Joseph GPresident and CEO; DirectorFeb 28Buy33.201,00033,20022,436Mar 01 08:30 AM
LAND RAYMOND JDirectorFeb 26Sale33.064,000132,24014,992Feb 28 04:34 PM